新生儿卡介苗免疫对婴儿异源疫苗应答的影响
在一项随机试验中,研究者比较了91名(45名接种BCG,46名未接种)婴儿在6周、4月、6月龄接种后1个月的抗体,以及310名(169名接种,141名未接种)婴儿接种后7个月的抗体;另在147名(78名接种,69名未接种)婴儿12月龄接种后1个月检测抗体。结果显示7月龄时两组血清保护率均高,13月龄时保护率下降,尤其百日咳和部分肺炎球菌抗原,但BCG接种者肺炎球菌抗原保护率普遍更高;BCG接种者白喉、破伤风、肺炎球菌抗体应答在7和13月龄持续较高(未达统计学显著),麻疹和腮腺炎在13月龄较高,Hib在7和13月龄接种后1个月较低。结论认为BCG对异源疫苗抗体应答的免疫调节作用增加了出生时BCG接种对婴儿免疫系统具有广泛异源效应的证据。
要点
- 7月龄时BCG接种与未接种婴儿血清保护率均高。
- 13月龄时保护率下降,尤其百日咳和部分肺炎球菌抗原。
- BCG接种者肺炎球菌抗原保护率普遍更高。
核心结论
- BCG对异源疫苗抗体应答的免疫调节作用增加了出生时BCG接种对婴儿免疫系统具有广泛异源效应的证据。
研究设计与样本
- 随机试验中,91名(45名接种BCG,46名未接种)婴儿在6周、4月、6月龄接种后1个月检测抗体;310名(169名接种,141名未接种)婴儿在接种后7个月检测;147名(78名接种,69名未接种)婴儿在12月龄接种后1个月检测。
主要发现
- 7月龄时BCG接种与未接种婴儿血清保护率均高。
- 13月龄时血清保护率低于7月龄,尤其百日咳和部分肺炎球菌抗原,但BCG接种者肺炎球菌抗原保护率普遍更高。
- BCG接种者白喉、破伤风、肺炎球菌抗体应答在7和13月龄持续较高(未达统计学显著)。
- BCG接种者麻疹和腮腺炎抗体在13月龄较高(未达统计学显著)。
- BCG接种者Hib抗体在7和13月龄接种后1个月较低(未达统计学显著)。
关键数值与推荐
- 比较BCG接种与未接种婴儿的血清保护率和抗体几何平均浓度(GMC)。
临床怎么用
- 出生时BCG接种可能对后续常规婴儿疫苗的抗体应答产生异源影响,评估疫苗效果时应考虑BCG接种状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Bacillus Calmette-Guérin vaccine (BCG), one of the most widely used vaccines, does not only provide protection against tuberculosis and other mycobacterial infections, but also has non-specific (heterologous) immunomodulatory effects. In participants in a randomised trial, we investigated the effect of neonatal BCG immunisation on antibody responses to routine infant vaccines given in the first year of life. METHODS: Antibodies against antigens in the diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), and the 13-valent pneumococcal conjugate vaccines were measured in 91 (45 BCG-vaccinated, 46 BCG-naïve) infants one month after, and in 310 (169 BCG-vaccinated, 141 BCG-naïve) infants seven months after immunisation at 6 weeks, 4 and 6 months of age. In addition, antibodies against meningococcus C, Hib, measles, mumps, and rubella were measured in 147 (78 BCG-vaccinated, 69 BCG-naïve) infants one month after immunisation at 12 months of age. The seroprotection rates for each vaccine and the geometric mean concentrations (GMC) of antibodies were compared in BCG-vaccinated and BCG-naïve infants. RESULTS: At 7 months of age, seroprotection rates were high in both BCG-vaccinated and BCG-naïve infants. At 13 months of age, seroprotection rates were lower than at 7 months of age, particularly for pertussis and a number of pneumococcal antigens, with generally higher rates for the latter in BCG-vaccinated infants. Although not statistically significant, antibody responses in BCG-vaccinated infants were consistently higher against diphtheria, tetanus, and pneumococcal antigens at both 7 and 13 months of age, and against measles and mumps at 13 months of age, but were lower against Hib one month after immunisation at both 7 and 13 months of age. CONCLUSION: The immunomodulatory effect of BCG on antibody responses to heterologous vaccines adds to the evidence that BCG immunisation at birth has broad heterologous effects on the infant immune system.
引用
- Zimmermann P, Donath S, Perrett KP, et al. The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants. Vaccine. 2019. PMID: 31153688. doi:10.1016/j.vaccine.2019.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。